Synapse Open Synapse
Biology

Editor’s pick: Bioptimus

Nature Biotechnology ·

Each year, Nature Biotechnology highlights companies that received sizeable early-stage funding in the previous year. Bioptimus is developing multimodal and multiscale AI pathology models for biomarker and drug treatment prediction.

Latest from Nature Biotechnology